Samantha McSherry Joins Telix as Director of Commercial Operations ANZ

24 August 2021 – Corporate Spotlight | Telix announces the appointment of  Samantha McSherry as Director of Commercial Operations ANZ.

Telix is delighted to announce that Samantha McSherry has joined Telix as Director of Commercial Operations for Australia and New Zealand.

Samantha joins Telix from Advanced Accelerator Applications (AAA), a Novartis Company, where she held the position of National and Strategic Account Manager, based in California, USA. Samantha brings over 20 years’ experience in consultative sales, account management, and contract negotiation at global companies covering a variety of sectors including pharmaceutical and biotechnology, and medical devices. She has held senior commercial positions with companies such as GE HealthcarePhilips, and Stryker Medical.

Samantha holds a Bachelor of Science in Human Services from Springfield College, Massachusetts where she graduated Magna cum laude.

On joining Telix, Ms. McSherry stated, “I am excited to be joining Telix and look forward to bringing illuccix®to the Australian and New Zealand markets.  Nuclear Medicine and theranostics are advancing at a phenomenal pace and I am so glad that I can be a part of this exciting journey.

Dr. David Cade, President Telix APAC added, “I’m delighted to welcome Samantha to Telix, as we transition to a commercial stage radiopharmaceutical company and prepare to launch our first product illuccix® for prostate cancer imaging in the Asia Pacific Region. Samantha brings to Telix a wealth of theranostics and nuclear medicine experience gained from her prior organisations AAA-Novartis and GE Healthcare. I look forward to working with Samantha to bring state-of-the-art prostate cancer imaging to patients across the region”.    

We welcome Samantha to the Telix team, as we work to deliver on the promise of nuclear medicine.

To return to our home page please click here.